Dormancy is an elusive and deadly component of cancers. Rare, therapy resistant cells lay dormant for decades and when reactivated cause disease progression and relapse. Eradicating dormant cancer cells is the key to curing cancers yet is an unrealized goal. New thinking and new strategies are required to achieve this. We are tackling this in some of the most difficult to treat cancers, including multiple myeloma, an incurable blood cancer that affects approximately 1800 Australians and approximately 138,000 individuals globally each year.
Predicting time to environment-dependent emergence of myeloma in patients (PreEEMPT)
Chief Investigators:
Garvan Institute of Medical Research,, Victoria Street, Darlinghurst NSW 2010
Kinghorn Cancer Centre, 370 Victoria Rd, Darlinghurst, NSW, 2010, Australia
School of Mathematics and Statistics, University of New South Wales, Sydney NSW 2052, The Red Centre, Room 3061,
